﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>7</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2021</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Efficacy and side effects of Sputnik V, Sinopharm and AstraZeneca vaccines to stop COVID-19; a review and discussion</ArticleTitle>
    <FirstPage>e31</FirstPage>
    <LastPage>e31</LastPage>
    <ELocationID EIdType="doi">10.34172/ipp.2021.31</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nasrin</FirstName>
        <LastName>Ghiasi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3954-2045</Identifier>
      </Author>
      <Author>
        <FirstName>Rohollah</FirstName>
        <LastName>Valizadeh</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-6913-3210</Identifier>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Arabsorkhi</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9333-8307</Identifier>
      </Author>
      <Author>
        <FirstName>Tahere Sadat</FirstName>
        <LastName>Hoseyni</LastName>
      </Author>
      <Author>
        <FirstName>Korosh</FirstName>
        <LastName>Esfandiari</LastName>
      </Author>
      <Author>
        <FirstName>Tella</FirstName>
        <LastName>Sadighpour</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3131-3339</Identifier>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Jahantigh</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ipp.2021.31</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>04</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2021</Year>
        <Month>05</Month>
        <Day>23</Day>
      </PubDate>
    </History>
    <Abstract>We believe that vaccination is just a way to eliminate or strongly stop the COVID-19. In this regard, there are several vaccines with different efficacy and side effects. It is urgently required to have some efficient vaccines for the prevention and control of SARS-CoV-2. In this review, international databases were considered for searching relevant articles from 1 January 2020 to 1 May 2021. Keywords were COVID-19, novel coronavirus, 2019- nCoV, coronavirus disease 2019, vaccine, Sputnik V, Gamaleya, Gam-COVID-Vac, Sinopharm, BBIBP-CorV, AstraZeneca, Vaxzevria, Oxford, ChAdOx1 nCoV-19 and AZD1222. Three Sputnik V, Sinopharm and AstraZeneca vaccines are useful to gain herd immunity. Enough intervals (at least three weeks/21 days) must be considered for sufficient neutralizing antibody titers. What is important is that the vaccination should be accelerated with each of the aforementioned three vaccines to achieve herd immunity in a shorter period of time because all three vaccines provide 100% prevention of severe COVID-19.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">COVID-19</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Novel coronavirus</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">2019-nCoV</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Vaccine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Sputnik V</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Gamaleya</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>